• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

GenSight - Articles and news items

Promising Phase I/II results for GenSight’s GS010 in LHON

Industry news / 9 June 2016 / Victoria White, Digital Content Producer

The Phase I/II study was designed to demonstrate the safety and tolerability of GS010 in 15 patients with Leber’s Hereditary Optic Neuropathy…